Desmoplastic Melanoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery (NCT02775851) | National Cancer Institute (NCI) | 2017-02-06 |
Track Desmoplastic Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.